| Literature DB >> 26552770 |
John Leung1, Koen Robert Beukema2, Alice Hangzhou Shen3.
Abstract
Eosinophilic oesophagitis (EoE) is characterized by oesophageal dysfunction and oesophageal eosinophilia refractory to proton-pump-inhibitor treatment. EoE is a food allergy, as elimination of food trigger(s) abrogates the disease, while trigger reintroduction causes recurrence. The allergic mechanism of EoE involves both IgE and non-IgE processes. There is a break in oral tolerance, the immune mechanism allowing enteric exposure to food and micro-organisms without causing deleterious immune responses. Changes in life-style, alterations in gut flora and use of antibiotics may be increasing disease prevalence. Mouse models of EoE and human studies revealed the role of regulatory T-cells and iNKT-cells in the pathogenesis. Th2-cytokines like IL-4, IL-5 and IL-13, and other cytokines like TGFβ and TSLP are involved, but perhaps no one cytokine is critically important for driving the disease. Control of EoE may require a pharmaceutical approach that blocks more than one target in the Th2-inflammatory pathway.Entities:
Keywords: Allergic mechanism; Antigen sensitization; Barrier dysfunction; Eosinophilic oesophagitis; Food allergy; Oral tolerance; Pathogenesis; t-helper lymphocyte type 2 immunity
Mesh:
Substances:
Year: 2015 PMID: 26552770 PMCID: PMC4919901 DOI: 10.1016/j.bpg.2015.09.012
Source DB: PubMed Journal: Best Pract Res Clin Gastroenterol ISSN: 1521-6918 Impact factor: 3.043